MEDINET Japan and Stempeutics India sign option licence agreement for Stempeucel in Japan

Lundbeck makes bid for Avadel, trying to displace Alkermes

DRRA36 minutes ago 0

PharmaShots Weekly Snapshots (Nov 10, 2025 – Nov 14, 2025)     

DRRA40 minutes ago 0

Adagene Enters ~$845M Licensing Deal with Third Arc Bio to Develop Masked CD3 T Cell Engagers

DRRA2 hours ago 0

Kura scores FDA okay for rival to Syndax’s leukaemia drug

DRRA2 hours ago 0